These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14909709)

  • 1. [Problem of cancer of the prostate. II. Principles and practice of endocrine therapy; immediate results; treated cancer; new clinical data].
    HAIMOVICI JL
    Med Gen Fr; 1951 Dec; 11(12):221-5. PubMed ID: 14909709
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine therapy for prostate cancer.
    Damber JE
    Acta Oncol; 2005; 44(6):605-9. PubMed ID: 16165920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immediate and remote results of hormone treatment of prostate cancer].
    ROZHDESTVENSKII VI
    Urol Mosc; 1957; 22(2):34-8. PubMed ID: 13456075
    [No Abstract]   [Full Text] [Related]  

  • 4. Fine-needle aspiration diagnosis of plasmacytoma presenting as breast masses in a patient on estrogen therapy for prostate cancer.
    Vetto JT; Beer TM; Fidda N; Ham B; Jimenez-Lee R; Schmidt W
    Diagn Cytopathol; 2004 Dec; 31(6):417-9. PubMed ID: 15540181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Remote results of hormonal therapy of cancer of the prostate].
    RYBINSKI K; SOSINSKI R
    Urol Pol; 1956; 9():107-9. PubMed ID: 13401615
    [No Abstract]   [Full Text] [Related]  

  • 6. [Remarks on combined hormone therapy of prostate cancer with estrogens and cortisone].
    PECHERSTORFER M; ULLRICH G
    Krebsarzt; 1957 Feb; 12(1):8-21. PubMed ID: 13417541
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percentage of positive biopsy cores at the onset of hormone therapy for prostate cancer: prognostic significance.
    Normand G; Celhay O; Briffaux R; Pirès C; Doré B; Fromont G; Irani J
    Urol Int; 2009; 83(2):160-5. PubMed ID: 19752610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Five years of medical therapy of cancer of the prostate; clinico-statistical findings].
    ARRIGONI G; CHIEREGO F
    G Ital Chemioter; 1956; 3(3-4):575-7. PubMed ID: 13462212
    [No Abstract]   [Full Text] [Related]  

  • 11. [Time-course of plasma testosterone in patients with prostate cancer treated by endocrine therapy].
    Peyromaure M; Rebillard X; Ruffion A; Salomon L; Villers A; Soulie M;
    Prog Urol; 2008 Jan; 18(1):2-8. PubMed ID: 18342148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in tissue prostatic acidic phosphatase during endocrine treatment of patients with prostatic carcinoma.
    Grande M; Carlström K; Lundh-Rozell B; Stege R; Pousette A
    Scand J Urol Nephrol; 2005; 39(5):393-8. PubMed ID: 16257841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers.
    Rau KM; Kang HY; Cha TL; Miller SA; Hung MC
    Endocr Relat Cancer; 2005 Sep; 12(3):511-32. PubMed ID: 16172190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer?
    Karlsson CT; Malmer B; Wiklund F; Grönberg H
    J Urol; 2006 Aug; 176(2):538-43. PubMed ID: 16813884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of prostate; proved rules from the practice for the practice].
    ENGEL G
    Munch Med Wochenschr; 1957 Sep; 99(36):1298-300. PubMed ID: 13483479
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group Study 5.
    Jønler M; Nielsen OS; Groenvold M; Hedlund PO; Damber L; Hedelin H; Waldén M;
    Scand J Urol Nephrol; 2005; 39(1):42-8. PubMed ID: 15764270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens and aspects of prostate disease.
    Prezioso D; Denis LJ; Klocker H; Sciarra A; Reis M; Naber K; Lobel B; Pacik D; Griffiths K
    Int J Urol; 2007 Jan; 14(1):1-16. PubMed ID: 17199853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2 New therapeutics in cancer of the prostate].
    DARGET R
    J Int Coll Surg; 1957 Nov; 28(5 Pt 1):666-72. PubMed ID: 13475933
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].
    Kameoka H; Katayose K; Kumakawa K; Shiraiwa Y; Uchida H; Takahashi Y; Yazaki J; Yamaguchi O
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):57-63. PubMed ID: 15675583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone therapy for prostate cancer].
    Théodore C
    Bull Cancer; 2004 Jan; 91(1):69-74. PubMed ID: 14975807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.